Zobrazeno 1 - 10
of 83
pro vyhledávání: '"R. Scipione"'
Autor:
Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M. Lagnf, Taylor Morrisette, Kyle C. Molina, Alaina DeKerlegand, Melanie Rae Schrack, S. Lena Kang-Birken, Athena L.V. Hobbs, Jazmin Agee, Nicholson B. Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A. King, Benjamin M. Pullinger, Kimberly C. Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P. Veve, Bruce M. Jones, Leonor M. Rojas, Amy K. Feehan, Marco R. Scipione, Jing J. Zhao, Paige Witucki, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 1 (2024)
ABSTRACT Eravacycline is a synthetic fluorocycline approved by the U.S. Food and Drug Administration in 2018. This study aimed to describe clinical and microbiological outcomes in addition to associated adverse effects of eravacycline used in U.S. ho
Externí odkaz:
https://doaj.org/article/c7670c6ad2ab4a279e5ee3917f0e0369
Autor:
Sara Alosaimy, Taylor Morrisette, Abdalhamid M. Lagnf, Leonor M. Rojas, Madeline A. King, Benjamin M. Pullinger, Athena L. V. Hobbs, Nicholson B. Perkins, Michael P. Veve, Jeannette Bouchard, Tristan Gore, Bruce Jones, James Truong, Justin Andrade, Glen Huang, Reese Cosimi, S. Lena Kang-Birken, Kyle C. Molina, Mark Biagi, Michael Pierce, Marco R. Scipione, Jing J. Zhao, Susan L. Davis, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT Forty-six patients were treated with eravacycline (ERV) for Acinetobacter baumannii infections, where 69.5% of isolates were carbapenem resistant (CRAB). Infections were primarily pulmonary (58.3%), and most patients received combination the
Externí odkaz:
https://doaj.org/article/3784b810c9054f3dafb994059224b8c7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cristian Merchan, Sunita Parajuli, Justin Siegfried, Marco R. Scipione, Yanina Dubrovskaya, Joseph Rahimian
Publikováno v:
Case Reports in Infectious Diseases, Vol 2016 (2016)
We describe a case of Bacteroides fragilis bacteremia associated with paraspinal and psoas abscesses in the United States. Resistance to b-lactam/b-lactamase inhibitors, carbapenems, and metronidazole was encountered despite having a recent travel hi
Externí odkaz:
https://doaj.org/article/12c3a649fde744fba711313d9d9a97bf
Autor:
Veena Venugopalan, Abdalhamid M Lagnf, Lee Amaya, Kyle C Molina, Jinhee Jo, Michael P. Veve, David Allen, Stephen Saw, Kevin W. Garey, Taylor Morrisette, Michael J. Rybak, Susan L. Davis, Lilian M. Abbo, Kimberly C. Claeys, Travis J Carlson, Vasilios Athans, Jessica K. Ortwine, Sarah C J Jorgensen, Ana D Vega, Kailynn DeRonde, Wesley D Kufel, Marco R Scipione, Christine Yost, Ryan P. Mynatt, Jing J. Zhao, Mathew Miller, Sara Alosaimy
Publikováno v:
Open Forum Infectious Diseases
Background We aimed to describe the clinical characteristics and outcomes of patients treated with meropenem-vaborbactam (MEV) for a variety of gram-negative infections (GNIs), primarily including carbapenem-resistant Enterobacterales (CRE). Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b5c562a52a78ecc086efc812947577
https://doi.org/10.1093/ofid/ofab371
https://doi.org/10.1093/ofid/ofab371
Publikováno v:
Open Forum Infectious Diseases
Background Inpatient antibiotic use early on in the COVID-19 pandemic may have increased due to the inability to distinguish between bacterial and COVID-19 pneumonia. The purpose of this study was to determine the impact of COVID-19 on antimicrobial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80a3b2d84b1f546ed44420f4c1be484
http://europepmc.org/articles/PMC8645026
http://europepmc.org/articles/PMC8645026
Autor:
Sara, Alosaimy, Abdalhamid M, Lagnf, Taylor, Morrisette, Sarah C J, Jorgensen, Trang D, Trinh, Evan J, Zasowski, Marco R, Scipione, Jing J, Zhao, Ryan, Mynatt, Shelbye, Herbin, Sorabh, Dhar, Teena, Chopra, James, Janisse, Nicholas, Rebold, Jason M, Pogue, Michael J, Rybak
Publikováno v:
Open Forum Infectious Diseases
Background Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) management remains challenging for clinicians. Numerous in vitro studies report synergy when vancomycin (VAN) and daptomycin (DAP) are combined with beta-lactam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef42155e8c1b0a3aeac4c0e460a5708b
https://pubmed.ncbi.nlm.nih.gov/34258313
https://pubmed.ncbi.nlm.nih.gov/34258313
Autor:
Shelbye R Herbin, Amina Ammar, Ryan Gumbleton, Jing Zhao, Shannon Olson, Stephanie M Smith, Marco R Scipione
Publikováno v:
Open Forum Infectious Diseases
Background Acinetobacter (ACB) infections are difficult to treat due to increasing drug resistance. The aim of this study is to evaluate the effectiveness of high-dose (HD) minocycline (MIN) 200mg q12h for the treatment of ACB infections Methods This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a760034df32e70f53113111ccef378d
http://europepmc.org/articles/PMC8644103
http://europepmc.org/articles/PMC8644103
Autor:
Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, Kyle Molina, Jeannette Bouchard, Tristan Gore, Lena Kang-Birken, Athena L Hobbs, Nicholson Perkins, Kimberly C Claeys, Madeline King, Benjamin Pullinger, Mark Biagi, Michael Pierce, Serina Tart, Michael P Veve, Leonor Rojas, Bruce M Jones, James Truong, Justin A Andrade, Reese Cosimi, Glen Huang, Marco R Scipione, Jing Zhao, Nicholas Rebold, Dana Holger, Susan L Davis, Michael J Rybak
Publikováno v:
Open Forum Infectious Diseases. 8:S733-S733
Background Eravacycline (ERV) is approved in the United States (US) for the treatment of complicated intra-abdominal infections in adults. We aimed to evaluate the independent predictors of clinical success in patients treated with ERV for various in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5c1b724a7737a1a86c86269fe1a38c9
https://doi.org/10.1093/ofid/ofab466.1480
https://doi.org/10.1093/ofid/ofab466.1480
Autor:
Yanina Dubrovskaya, Justin Siegfried, Arash Dabestani, Cristian Merchan, Marco R. Scipione, John Papadopoulos
Publikováno v:
American Journal of Health-System Pharmacy. 74:417-423
Purpose The integration of pharmacy residents into an antimicrobial stewardship program (ASP) is described, and data on the residents’ ASP interventions and outcomes are reported. Summary ASP coverage of nighttime, holiday, and weekend shifts is of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e98dd362824e07b778c8d982075ea00
https://doi.org/10.2146/ajhp160133
https://doi.org/10.2146/ajhp160133